International Journal of Infectious Diseases

Slides:

Advertisements

Similar presentations

ESBL producing Pseudomonas aeruginosa resistant to CAZ, ATM, FEP, borderline resistant to PIP, susceptible to TIM and TZP. Note the synergy between TIM.

Advertisements

Plasmid mediated Metallo-Beta- Lactamase (MBL) Plasmid mediated Hydrolyses all beta-lactam (except aztreonam) Inhibited by EDTA Binds zinc (Zn 2+ ) Pseudomonas.

Antimicrobial resistance surveillance in Ireland Results of invasive Pseudomonas aeruginosa infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

n°10 : Klebsiella pneumoniae

Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Resistance in Pseudomonas aeruginosa and Acinetobacter spp. from blood in the UK and Ireland Rosy Reynolds, Russell Hope, BSAC Working Party.

Nosocomial E. coli Urine Isolates 1991 – Nosocomial K. pneumoniae Urine Isolates

Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Nosocomial E. coli Urine Isolates Nosocomial K. pneumoniae Urine Isolates

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Development of a foundation for a case definition of post-treatment Lyme disease syndrome John N. Aucott, Lauren A. Crowder, Kathleen B. Kortte International.

Robert Koch and the ‘golden age’ of bacteriology Steve M. Blevins, Michael S. Bronze International Journal of Infectious Diseases Volume 14, Issue 9, Pages.

Syndromic classification of rickettsioses: an approach for clinical practice Álvaro A. Faccini-Martínez, Lara García-Álvarez, Marylin Hidalgo, José A.

Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.

Antimicrobial Resistance at GLA

D. Sauerwein International Journal of Antimicrobial Agents

Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China Y. Chen,

EARS-Net data on Antimicrobial Resistance in Ireland, Q

Antonio Cascio, Chiara Iaria, Paolo Ruggeri, Walter Fries

The Role of the Microbiology Laboratory in AMS programs

International Journal of Infectious Diseases

F.M. MacKenzie, C.A. Miller, I.M. Gould

Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli,

Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type A.K. Van der Bij, D. Van.

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times F.B. Spencker, L. Staber, T. Lietz,

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.

Purple urine bag syndrome in a hemodialysis patient

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98 J. Robert, E. Cambau, K. Grenet, D.

L. Poirel, P. Nordmann Clinical Microbiology and Infection

Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections

A.G.G. Lødeng, C. Ahlén, H. Lysvand, L.H. Mandal, O.J. Iversen

Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.

Strategies for selecting antibiotics in intensive care units

A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals M. Nagao Clinical Microbiology and.

Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and.

The need for new antibiotics

EXTENDED SPECTRUM β-LACTAMASE PRODUCING GRAM NEGATIVE BACTERIA ISOLATED FROM INFECTED WOUND OF ORTHOPEDIC PATIENTS Shwe Phyu Aung , Thandar Win Maung,

Inga Odenholt, Elisabeth Löwdin, Otto Cars

Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models D.L. Monnet, J.-M. López-Lozano,

Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum β-lactamases (ESBL) in Enterobacteriaceae S. Polsfuss, G.V.

Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide L. Drieux, F. Brossier, W. Sougakoff,

Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany E. Raum, S. Lietzau,

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study Patrick Musicha,

Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria Inga Odenholt, Elisabeth Löwdin,

Strategies for selecting antibiotics in intensive care units

M.R. Jacobs Clinical Microbiology and Infection

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Impact of urinary tract infections on short-term kidney graft outcome

Abstracts cont. Clinical Microbiology and Infection

J. Buijs, A. S. M. Dofferhoff, J. W. Mouton, J. H. T. Wagenvoort, J. W

I. Faria-Ramos, M. J. Espinar, R. Rocha, J. Santos-Antunes, A. G

Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases L. Romero, L. López,

Outbreak reporting a decade after ORION: where do we stand?

Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli W.

Highly antibiotic-resistant Acinetobacter baumannii clinical isolates are killed by the green tea polyphenol (–)-epigallocatechin-3-gallate (EGCG) A.

Jacques Sirot Clinical Microbiology and Infection

Evolving problems with resistant pathogens

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit S. Nseir, C. Blazejewski, R. Lubret,

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

Profile of Pseudomonas aeruginosa resistance by country and antibiotic

Assessment of the usefulness of performing bacterial identification and antimicrobial susceptibility testing 24 h a day in a clinical microbiology laboratory

Antibiotic overconsumption and resistance in Turkey

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

G. Kahlmeter Clinical Microbiology and Infection

Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:

Figure 1. Rates of IEAT and AEAT in most common microorganisms causing inappropriate treatment. Abbreviations: AEAT, ... Figure 1. Rates of IEAT and AEAT.

Clinical Microbiology and Infection

Serotypes, genotypes and antimicrobial resistance patterns of human diarrhoeagenic Escherichia coli isolates circulating in southeastern China Y. Chen,

Presentation transcript:

International Journal of Infectious Diseases Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011– 2013 Wail A. Hayajneh, Aline Hajj, Fawzi Hulliel, Dolla Karam Sarkis, Noha Irani-Hakimeh, Lama Kazan, Robert E. Badal International Journal of Infectious Diseases Volume 35, Pages 56-61 (June 2015) DOI: 10.1016/j.ijid.2015.04.011 Copyright © 2015 The Authors Terms and Conditions

Figure 1 Antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae (ESBL and non-ESBL producers) associated with UTI in Jordan and Lebanon SMART centres, 2011–2013. (CRO, ceftriaxone; CAZ, ceftazidime; FEP, cefepime; SAM, ampicillin–sulbactam; CIP, ciprofloxacin; LVX, levofloxacin; TZP, piperacillin–tazobactam; AMK, amikacin; ETP, ertapenem; IPM, imipenem). International Journal of Infectious Diseases 2015 35, 56-61DOI: (10.1016/j.ijid.2015.04.011) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis (ESBL and non-ESBL producers) associated with intra-abdominal infections in Jordan and Lebanon SMART centres, 2011–2013. (CRO, ceftriaxone; CAZ, ceftazidime; FEP, cefepime; SAM, ampicillin–sulbactam; CIP, ciprofloxacin; LVX, levofloxacin; TZP, piperacillin–tazobactam; AMK, amikacin; ETP, ertapenem; IPM, imipenem). International Journal of Infectious Diseases 2015 35, 56-61DOI: (10.1016/j.ijid.2015.04.011) Copyright © 2015 The Authors Terms and Conditions

Figure 3 Antimicrobial susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii associated with UTI in Jordan and Lebanon SMART centres, 2011–2013. (CIP, ciprofloxacin; LVX, levofloxacin; CAZ, ceftazidime; FEP, cefepime; AMK, amikacin; TZP, piperacillin–tazobactam; IPM, imipenem. The numbers reported on the histogram refer to the percentage of susceptibility). International Journal of Infectious Diseases 2015 35, 56-61DOI: (10.1016/j.ijid.2015.04.011) Copyright © 2015 The Authors Terms and Conditions

Figure 4 Antimicrobial susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii associated with IAI in Jordan and Lebanon SMART centres, 2011–2013. (CIP, ciprofloxacin; LVX, levofloxacin; CAZ, ceftazidime; FEP, cefepime; AMK, amikacin; TZP, piperacillin–tazobactam; IPM, imipenem). International Journal of Infectious Diseases 2015 35, 56-61DOI: (10.1016/j.ijid.2015.04.011) Copyright © 2015 The Authors Terms and Conditions